Algert Global’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-127,698
Closed -$1.43M 1159
2024
Q3
$1.43M Sell
127,698
-11,010
-8% -$117K 0.04% 670
2024
Q2
$1.39M Sell
138,708
-17,932
-11% -$182K 0.05% 579
2024
Q1
$1.8M Sell
156,640
-8,060
-5% -$68.5K 0.07% 444
2023
Q4
$1.2M Buy
164,700
+48,820
+42% +$385K 0.05% 572
2023
Q3
$1.05M Buy
115,880
+69,800
+151% +$837K 0.05% 557
2023
Q2
$561K Buy
+46,080
New +$514K 0.02% 791

Other funds holding AHCO

Algert Global's AHCO Position: Q4 2024 in Review

Algert Global sold out of AdaptHealth (AHCO) in Q4 2024, closing a stake of 127,698 shares — an estimated $1.43M sold.

Algert Global first reported a position in AHCO in Q2 2023 and held it in 6 quarters. The position peaked at $1.8M in Q1 2024. 200 funds tracked by Wall St. Rank hold AHCO as of Q4 2024.

  • Algert Global reported no remaining AdaptHealth position as of Q4 2024 after selling out during the quarter.
  • Algert Global sold 127,698 AdaptHealth shares in Q4 2024, an estimated $1.43M.
  • Algert Global first reported a position in AdaptHealth in Q2 2023 and held it in 6 quarters.
  • Algert Global's AdaptHealth position peaked at $1.8M in Q1 2024.
  • 200 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2024.

Based on Algert Global's 13F filing for Q4 2024, filed 14 Feb 2025.